Literature DB >> 29353970

Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014.

Xueting Li1, Rongshou Zheng2, Xuemei Li3, Haibin Shan4, Qi Wu5, Yan Wang1, Wanqing Chen2.   

Abstract

OBJECTIVE: To analyze the trends of incidence rate and age at diagnosis for cervical cancer incidence in China using population-based cancer registration data from 2000 to 2014.
METHODS: Data were from National Central Cancer Registry of China. Crude incidence rates (CIRs), age-specific incidence rate, age-standardized incidence rates (ASIRs), age percentage distribution, standardized age percentage distribution, mean age at diagnosis and standardized mean age at diagnosis for cervical cancer in all areas of China, urban China and rural China were calculated separately. The world Segi's population was applied to remove the age structure influence. Joinpoint regression was performed to obtain average annual percent change (AAPC) and age-period-cohort analysis was used to examine the incidence trends.
RESULTS: CIRs and ASIRs for cervical cancer increased in China from 2000 to 2014. The AAPC of ASIRs in China was at 9.2% [95% confidence interval (95% CI): 7.0%-11.5%, P<0.05], and the AAPC in rural areas was relatively high. The age-specific incidence rate in groups aged 0-69 years have significantly increased over time. Groups aged 40-69 years showed the highest incidence risk, and the annual percent changes (APCs) of incidence rate in groups aged 40-59 years in urban China and groups aged 0-49 years in rural China were more than 10%. For each age group, the urban-to-rural incidence rate ratios (IRRs) got close to 1 over time. There were clear birth cohort effects in successive generations born from 1940 to 1970 in China. In rural China, the standardized mean age at diagnosis had significantly declined by 5.18 years. In China, the main peak and secondary peak of standardized age percentages appeared in the groups aged 45-49 and 40-44 years, respectively. In rural China, the main peak of standardized age percentage moved from the group aged 55-59 years to the group aged 45-49 years, and the standardized age percentages of groups aged 25-34 years also increased. In China, the standardized age percentages has significantly increased in groups aged 35-64 and 30-64 years over time, and accounted for about 80% and 85% in 2014, respectively.
CONCLUSIONS: The cervical cancer incidence increased in China and the gap of incidence between urban and rural China was narrowed. The trends of increasing cervical cancer incidence among younger women existed in China, especially in rural China. A more appropriate screening, vaccination and health education strategies should be established.

Entities:  

Keywords:  Cervical cancer; age; incidence

Year:  2017        PMID: 29353970      PMCID: PMC5758729          DOI: 10.21147/j.issn.1000-9604.2017.06.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  21 in total

1.  Trends in cervical cancer in young women in Hubei, China.

Authors:  Hong-Bing Cai; Xiao-Mei Liu; Yi Huang; Xiao-Nan Li; Dao-Mei Lie; Quan Zhou; Feng-Lian Pan; Zu-Hui Wang; Zhi-Yin Li; Xiao-Yan Wang; Yin Dai
Journal:  Int J Gynecol Cancer       Date:  2010-10       Impact factor: 3.437

2.  Cervical cancer screening policies and coverage in Europe.

Authors:  Ahti Anttila; Lawrence von Karsa; Auni Aasmaa; Muriel Fender; Julietta Patnick; Matejka Rebolj; Florian Nicula; Laszlo Vass; Zdravka Valerianova; Lydia Voti; Catherine Sauvaget; Guglielmo Ronco
Journal:  Eur J Cancer       Date:  2009-08-19       Impact factor: 9.162

3.  Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies.

Authors:  Fang-Hui Zhao; Adam K Lewkowitz; Shang-Ying Hu; Feng Chen; Long-Yu Li; Qing-Ming Zhang; Rui-Fang Wu; Chang-Qing Li; Li-Hui Wei; Ai-Di Xu; Wen-Hua Zhang; Qin-Jing Pan; Xun Zhang; Jerome L Belinson; John W Sellors; Jennifer S Smith; You-Lin Qiao; Silvia Franceschi
Journal:  Int J Cancer       Date:  2012-04-24       Impact factor: 7.396

4.  Annual report on status of cancer in China, 2011.

Authors:  Wanqing Chen; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Jie He
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

5.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

6.  Expenditure of hospital care on cancer in China, from 2011 to 2015.

Authors:  Yue Cai; Ming Xue; Wanqing Chen; Maogui Hu; Zhiwen Miao; Lan Lan; Rongshou Zheng; Qun Meng
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

7.  Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group.

Authors:  Shuang Li; Ting Hu; Weiguo Lv; Hang Zhou; Xiong Li; Ru Yang; Yao Jia; Kecheng Huang; Zhilan Chen; Shaoshuai Wang; Fangxu Tang; Qinghua Zhang; Jian Shen; Jin Zhou; Ling Xi; Dongrui Deng; Hui Wang; Shixuan Wang; Xing Xie; Ding Ma
Journal:  Oncologist       Date:  2013-09-16

8.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

9.  Assessment of psychological barriers to cervical cancer screening among women in Kumasi, Ghana using a mixed methods approach.

Authors:  M Williams; G Kuffour; E Ekuadzi; M Yeboah; M ElDuah; P Tuffour
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

Review 10.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

View more
  22 in total

1.  Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women.

Authors:  Xiaomeng Ma; Katherine Harripersaud; Kumi Smith; Christopher K Fairley; Huachun Zou; Zhuoru Zou; Yueyun Wang; Guihua Zhuang; Lei Zhang
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

2.  Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions.

Authors:  Jiao Li; Juan-Juan Gao; Na Li; Ya-Wen Wang
Journal:  Arch Virol       Date:  2021-01-24       Impact factor: 2.574

3.  Colorectal Cancer Incidence and Mortality Trends and Analysis of Risk Factors in China from 2005 to 2015.

Authors:  Chao Sun; Yan Liu; Yiman Huang; Bang Li; Weiqing Rang
Journal:  Int J Gen Med       Date:  2021-12-20

4.  [Silencing long non-coding RNA HIF1A-AS2 inhibits proliferation, invasion and migration of cervical cancer cells in vitro].

Authors:  Rong Deng; Fuyun Zhang; Fuzhen Lei; Wenjun Liu; Sisun Liu; Wenhua Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

5.  Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity.

Authors:  Sailaja Kamaraju; Jeffrey Drope; Rengaswamy Sankaranarayanan; Surendra Shastri
Journal:  Am Soc Clin Oncol Educ Book       Date:  2020-03

6.  The Regulatory Role of circRNA_101308 in Cervical Cancer and the Prediction of Its Mechanism.

Authors:  Jun Jiao; Xinlin Jiao; Qingqing Liu; Wenjie Qu; Daoxin Ma; Youzhong Zhang; Baoxia Cui
Journal:  Cancer Manag Res       Date:  2020-06-22       Impact factor: 3.989

7.  CDK6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females.

Authors:  Kailibinuer Aierken; Zhihong Dong; Tangnuer Abulimiti; Yuanyuan Zhang; Guzhalinuer Abuduxikuer; Gulixian Tuerxun; Guligeina Abudurexiti; Aziguli Maimaitiaishan; Patiman Mijiti; Guzhalinuer Abulizi
Journal:  Mol Genet Genomic Med       Date:  2019-03-04       Impact factor: 2.183

Review 8.  Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine.

Authors:  Xu Zhou; Lihua Sun; Xiaoxiao Yao; Guangquan Li; Yicun Wang; Yang Lin
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

9.  Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.

Authors:  Hua-Ju Yang; Jin-Min Xue; Jie Li; Ling-Hong Wan; Yu-Xi Zhu
Journal:  Mol Genet Genomic Med       Date:  2020-03-17       Impact factor: 2.183

10.  Knowledge and Attitudes Regarding HPV and Vaccination Among Chinese Women Aged 20 to 35 Years in Fujian Province: A Cross-Sectional Study.

Authors:  Lihua Chen; Yiyi Song; Guanyu Ruan; Qiaoyu Zhang; Fen Lin; Jun Zhang; Ting Wu; Jian An; Binhua Dong; Pengming Sun
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.